Anna Truini
Yale Cancer Center(US)Yale University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer(2017)730 cited
- → Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer(2018)447 cited
- → EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer(2019)360 cited
- → Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes(2014)152 cited
- → A Novel Serum 4-microRNA Signature for Lung Cancer Detection(2015)134 cited
- → Clinical Applications of Circulating Tumor Cells in Lung Cancer Patients by CellSearch System(2014)73 cited
- → Epigenetic Inactivation of microRNA-34b/c Predicts Poor Disease-Free Survival in Early-Stage Lung Adenocarcinoma(2013)62 cited
- → The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma(2019)60 cited
- → Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism(2017)60 cited
- → Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine(2014)50 cited